DATA 12-05-2022
PRIMA | DOPO |
---|---|
<005>20210209194749.0 <013>20210209134848.0 <710>Goodman, Louis Sanford^fAU^g700^i1^j070^kN^lN^xSBN^yUMCV013576^21 <711>Gilman, Alfred^fAU^g701^i2^j070^kN^lN^xSBN^yUMCV008119^21 <712>Brunton, Laurence L.^fAU^g702^i3^j340^xSBN^yUSMV751980^21 <712>Hilal-Dandan, Randa^fAU^g702^i3^j340^xSBN^yUBOV415510^21 <712>Knollmann, Bjorn C.^fAU^g702^i3^j340^xSBN^yUSMV956378^21 <739>615.7^bD^cFARMACOCINETICA^d23^fCL^g676^xSBN^yD23615.7 <760>Farmacologia^bFE^fSO^g606^xSBN^yCFIC002716 <760>Terapeutica^bFE^fSO^g606^xSBN^yCFIC002171 |
<005>20220511173337.0 <013>20220510182457.1 <500>Sul verso del frontespizio: Goodman & Gilman's pharmaceutical basis of the therapeutics <710>Goodman, Louis Sanford^fAU^g700^i1^j070^kN^lN^xSBN^yUMCV013576^520210420144019.5^21 <711>Gilman, Alfred^fAU^g701^i2^j070^kN^lN^xSBN^yUMCV008119^520150611105507.9^21 <712>Brunton, Laurence L.^fAU^g702^i3^j340^xSBN^yUSMV751980^520180126163306.7^21 <712>Gilman, Alfred Goodman^fAU^g702^i3^j340^kN^lN^xSBN^yCFIV120404^520190717101223.0^21 <712>Hilal-Dandan, Randa^fAU^g702^i3^j340^xSBN^yUBOV415510^520180126163642.7^21 <712>Knollmann, Bjorn C.^fAU^g702^i3^j340^xSBN^yUSMV956378^520180126163023.6^21 <739>615.7^bD^cFARMACOCINETICA^d23^fCL^g676^xSBN^yD23615.7^520190717104324.0 <760>Farmacologia^bFE^fSO^g606^xSBN^yCFIC002716^520220111160653.3 <760>Terapeutica^bFE^fSO^g606^xSBN^yCFIC002171^520210625132513.2 |